You are here

Byetta

Drugmakers pitch meds in the works for diabetes

Yahoo/AP

Sat, 06/6/09 - 10:17 am

Bristol-Myers Squibb

Amylin Seeks FDA Approval on Extended Byetta Treatment

WSJ Online

Tue, 05/5/09 - 10:35 am

Amylin: A Discounted Option on Byetta's Outcome

Seeking Alpha

Wed, 04/22/09 - 11:25 am

Amylin's Pullback Is Unjustified

Seeking Alpha

Fri, 04/10/09 - 08:28 am

Amylin Staunchly Defends Byetta

TheStreet.com

Tue, 04/7/09 - 11:19 am

Amylin rises, Novo falls on diabetes developments

Yahoo/AP

Tue, 03/31/09 - 12:53 pm

Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application

Yahoo/AP

Thu, 03/26/09 - 02:47 pm

Bristol-Myers Squibb

Amylin Shares Find Support, But Upside Still Limited

Seeking Alpha

Tue, 03/24/09 - 09:42 am

Amylin Looks Range-Bound

Yahoo/Zacks.com

Mon, 03/23/09 - 07:33 pm

Lazard sees Amylin's exenatide as a blockbuster

Yahoo/AP

Mon, 03/2/09 - 05:44 pm

Diabetes Drugs to Face Tougher Risk Scrutiny

WSJ Online

Thu, 12/18/08 - 07:15 am

Bristol-Myers Squibb

Amylin: Stay on Sidelines

Yahoo/Zacks.com

Tue, 12/16/08 - 05:32 pm

Pages